AMLX
Price
$4.58
Change
-$0.29 (-5.95%)
Updated
May 8 closing price
Capitalization
433.84M
90 days until earnings call
SNDX
Price
$11.01
Change
+$1.02 (+10.21%)
Updated
May 8 closing price
Capitalization
859.61M
94 days until earnings call
Ad is loading...

AMLX vs SNDX

Header iconAMLX vs SNDX Comparison
Open Charts AMLX vs SNDXBanner chart's image
Amylyx Pharmaceuticals
Price$4.58
Change-$0.29 (-5.95%)
Volume$2.09M
Capitalization433.84M
Syndax Pharmaceuticals
Price$11.01
Change+$1.02 (+10.21%)
Volume$3.61M
Capitalization859.61M
AMLX vs SNDX Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. SNDX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and SNDX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (AMLX: $4.58 vs. SNDX: $11.01)
Brand notoriety: AMLX and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 228% vs. SNDX: 169%
Market capitalization -- AMLX: $433.84M vs. SNDX: $859.61M
AMLX [@Biotechnology] is valued at $433.84M. SNDX’s [@Biotechnology] market capitalization is $859.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • SNDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AMLX and SNDX are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а -10.89% price change this week, while SNDX (@Biotechnology) price change was -20.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($860M) has a higher market cap than AMLX($434M). AMLX YTD gains are higher at: 21.164 vs. SNDX (-16.717). AMLX has higher annual earnings (EBITDA): -290.98M vs. SNDX (-313.82M). SNDX has more cash in the bank: 583M vs. AMLX (177M). AMLX has less debt than SNDX: AMLX (1.98M) vs SNDX (346M). AMLX has higher revenues than SNDX: AMLX (87.4M) vs SNDX (23.7M).
AMLXSNDXAMLX / SNDX
Capitalization434M860M50%
EBITDA-290.98M-313.82M93%
Gain YTD21.164-16.717-127%
P/E Ratio2.69N/A-
Revenue87.4M23.7M369%
Total Cash177M583M30%
Total Debt1.98M346M1%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXSNDX
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYPX30.410.12
+0.40%
American Beacon Man Lg Cp Growth Inv
SFILX13.94N/A
N/A
Schwab Fundamental Intl Sm Eq Idx
NBSRX47.85N/A
N/A
Neuberger Berman Sustainable Equity Inv
FUFRX24.14N/A
N/A
Franklin Utilities R6
EMQCX7.90N/A
N/A
Ashmore Emerging Markets Active Eq C